Global Urology Drugs Sales Market Report 2017

February 2017 | 126 pages | ID: G33718A6370EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Urology Drugs

Revenue, means the sales value of Urology Drugs

This report studies sales (consumption) of Urology Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Astellas
• Endo
• GP Pharm
• Tolmar

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Urology Drugs in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• α (alpha) - blockers
• 5 α-reductase inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Urology Drugs in each application, can be divided into

• Hospital
• Clinic

Contents

Global Urology Drugs Sales Market Report 2017

1 UROLOGY DRUGS OVERVIEW

1.1 Product Overview and Scope of Urology Drugs
1.2 Classification of Urology Drugs
  1.2.1 α (alpha) - blockers
  1.2.2 5 α-reductase inhibitors
1.3 Application of Urology Drugs
  1.3.1 Hospital
  1.3.2 Clinic
1.4 Urology Drugs Market by Regions
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Urology Drugs (2012-2022)
  1.5.1 Global Urology Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Urology Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL UROLOGY DRUGS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Urology Drugs Market Competition by Manufacturers
  2.1.1 Global Urology Drugs Sales and Market Share of Key Manufacturers (2012-2017)
  2.1.2 Global Urology Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Urology Drugs (Volume and Value) by Type
  2.2.1 Global Urology Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Urology Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Urology Drugs (Volume and Value) by Regions
  2.3.1 Global Urology Drugs Sales and Market Share by Regions (2012-2017)
  2.3.2 Global Urology Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Urology Drugs (Volume) by Application

3 UNITED STATES UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Urology Drugs Sales and Value (2012-2017)
  3.1.1 United States Urology Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Urology Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Urology Drugs Sales Price Trend (2012-2017)
3.2 United States Urology Drugs Sales and Market Share by Manufacturers
3.3 United States Urology Drugs Sales and Market Share by Type
3.4 United States Urology Drugs Sales and Market Share by Application

4 CHINA UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Urology Drugs Sales and Value (2012-2017)
  4.1.1 China Urology Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Urology Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Urology Drugs Sales Price Trend (2012-2017)
4.2 China Urology Drugs Sales and Market Share by Manufacturers
4.3 China Urology Drugs Sales and Market Share by Type
4.4 China Urology Drugs Sales and Market Share by Application

5 EUROPE UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Urology Drugs Sales and Value (2012-2017)
  5.1.1 Europe Urology Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Urology Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Urology Drugs Sales Price Trend (2012-2017)
5.2 Europe Urology Drugs Sales and Market Share by Manufacturers
5.3 Europe Urology Drugs Sales and Market Share by Type
5.4 Europe Urology Drugs Sales and Market Share by Application

6 JAPAN UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Urology Drugs Sales and Value (2012-2017)
  6.1.1 Japan Urology Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Urology Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Urology Drugs Sales Price Trend (2012-2017)
6.2 Japan Urology Drugs Sales and Market Share by Manufacturers
6.3 Japan Urology Drugs Sales and Market Share by Type
6.4 Japan Urology Drugs Sales and Market Share by Application

7 SOUTHEAST ASIA UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Urology Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Urology Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Urology Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Urology Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Urology Drugs Sales and Market Share by Type
7.4 Southeast Asia Urology Drugs Sales and Market Share by Application

8 INDIA UROLOGY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Urology Drugs Sales and Value (2012-2017)
  8.1.1 India Urology Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Urology Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Urology Drugs Sales Price Trend (2012-2017)
8.2 India Urology Drugs Sales and Market Share by Manufacturers
8.3 India Urology Drugs Sales and Market Share by Type
8.4 India Urology Drugs Sales and Market Share by Application

9 GLOBAL UROLOGY DRUGS MANUFACTURERS ANALYSIS

9.1 Astellas
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Urology Drugs Product Type, Application and Specification
    9.1.2.1 α (alpha) - blockers
    9.1.2.2 5 α-reductase inhibitors
  9.1.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Endo
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Urology Drugs Product Type, Application and Specification
    9.2.2.1 α (alpha) - blockers
    9.2.2.2 5 α-reductase inhibitors
  9.2.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 GP Pharm
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Urology Drugs Product Type, Application and Specification
    9.3.2.1 α (alpha) - blockers
    9.3.2.2 5 α-reductase inhibitors
  9.3.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Tolmar
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Urology Drugs Product Type, Application and Specification
    9.4.2.1 α (alpha) - blockers
    9.4.2.2 5 α-reductase inhibitors
  9.4.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview

10 UROLOGY DRUGS MAUFACTURING COST ANALYSIS

10.1 Urology Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Urology Drugs
10.3 Manufacturing Process Analysis of Urology Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Urology Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL UROLOGY DRUGS MARKET FORECAST (2017-2022)

14.1 Global Urology Drugs Sales, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Urology Drugs Sales and Growth Rate Forecast (2017-2022)
  14.1.2 Global Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Urology Drugs Price and Trend Forecast (2017-2022)
14.2 Global Urology Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.1 United States Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.2 China Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.3 Europe Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 Japan Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Southeast Asia Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 India Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Urology Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Urology Drugs Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Urology Drugs
Table Classification of Urology Drugs
Figure Global Sales Market Share of Urology Drugs by Type in 2015
Figure α (alpha) - blockers Picture
Figure 5 α-reductase inhibitors Picture
Table Applications of Urology Drugs
Figure Global Sales Market Share of Urology Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Urology Drugs Revenue and Growth Rate (2012-2022)
Figure China Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2022)
Figure India Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Global Urology Drugs Sales and Growth Rate (2012-2022)
Figure Global Urology Drugs Revenue and Growth Rate (2012-2022)
Table Global Urology Drugs Sales of Key Manufacturers (2012-2017)
Table Global Urology Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Urology Drugs Sales Share by Manufacturers
Figure 2016 Urology Drugs Sales Share by Manufacturers
Table Global Urology Drugs Revenue by Manufacturers (2012-2017)
Table Global Urology Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Urology Drugs Revenue Share by Manufacturers
Table 2016 Global Urology Drugs Revenue Share by Manufacturers
Table Global Urology Drugs Sales and Market Share by Type (2012-2017)
Table Global Urology Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Urology Drugs by Type (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Type (2012-2017)
Table Global Urology Drugs Revenue and Market Share by Type (2012-2017)
Table Global Urology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urology Drugs by Type (2012-2017)
Figure Global Urology Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Urology Drugs Sales and Market Share by Regions (2012-2017)
Table Global Urology Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Urology Drugs by Regions (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Urology Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Urology Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Urology Drugs by Regions (2012-2017)
Figure Global Urology Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Urology Drugs Sales and Market Share by Application (2012-2017)
Table Global Urology Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Urology Drugs by Application (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Urology Drugs Sales and Growth Rate (2012-2017)
Figure United States Urology Drugs Revenue and Growth Rate (2012-2017)
Figure United States Urology Drugs Sales Price Trend (2012-2017)
Table United States Urology Drugs Sales by Manufacturers (2012-2017)
Table United States Urology Drugs Market Share by Manufacturers (2012-2017)
Table United States Urology Drugs Sales by Type (2012-2017)
Table United States Urology Drugs Market Share by Type (2012-2017)
Table United States Urology Drugs Sales by Application (2012-2017)
Table United States Urology Drugs Market Share by Application (2012-2017)
Figure China Urology Drugs Sales and Growth Rate (2012-2017)
Figure China Urology Drugs Revenue and Growth Rate (2012-2017)
Figure China Urology Drugs Sales Price Trend (2012-2017)
Table China Urology Drugs Sales by Manufacturers (2012-2017)
Table China Urology Drugs Market Share by Manufacturers (2012-2017)
Table China Urology Drugs Sales by Type (2012-2017)
Table China Urology Drugs Market Share by Type (2012-2017)
Table China Urology Drugs Sales by Application (2012-2017)
Table China Urology Drugs Market Share by Application (2012-2017)
Figure Europe Urology Drugs Sales and Growth Rate (2012-2017)
Figure Europe Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Urology Drugs Sales Price Trend (2012-2017)
Table Europe Urology Drugs Sales by Manufacturers (2012-2017)
Table Europe Urology Drugs Market Share by Manufacturers (2012-2017)
Table Europe Urology Drugs Sales by Type (2012-2017)
Table Europe Urology Drugs Market Share by Type (2012-2017)
Table Europe Urology Drugs Sales by Application (2012-2017)
Table Europe Urology Drugs Market Share by Application (2012-2017)
Figure Japan Urology Drugs Sales and Growth Rate (2012-2017)
Figure Japan Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Urology Drugs Sales Price Trend (2012-2017)
Table Japan Urology Drugs Sales by Manufacturers (2012-2017)
Table Japan Urology Drugs Market Share by Manufacturers (2012-2017)
Table Japan Urology Drugs Sales by Type (2012-2017)
Table Japan Urology Drugs Market Share by Type (2012-2017)
Table Japan Urology Drugs Sales by Application (2012-2017)
Table Japan Urology Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Urology Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Urology Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Urology Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Urology Drugs Sales by Type (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Type (2012-2017)
Table Southeast Asia Urology Drugs Sales by Application (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Application (2012-2017)
Figure India Urology Drugs Sales and Growth Rate (2012-2017)
Figure India Urology Drugs Revenue and Growth Rate (2012-2017)
Figure India Urology Drugs Sales Price Trend (2012-2017)
Table India Urology Drugs Sales by Manufacturers (2012-2017)
Table India Urology Drugs Market Share by Manufacturers (2012-2017)
Table India Urology Drugs Sales by Type (2012-2017)
Table India Urology Drugs Market Share by Type (2012-2017)
Table India Urology Drugs Sales by Application (2012-2017)
Table India Urology Drugs Market Share by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Urology Drugs Global Market Share (2012-2017)
Table Endo Basic Information List
Table Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Endo Urology Drugs Global Market Share (2012-2017)
Table GP Pharm Basic Information List
Table GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GP Pharm Urology Drugs Global Market Share (2012-2017)
Table Tolmar Basic Information List
Table Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tolmar Urology Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urology Drugs
Figure Manufacturing Process Analysis of Urology Drugs
Figure Urology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
Table Major Buyers of Urology Drugs
Table Distributors/Traders List
Figure Global Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Urology Drugs Sales Forecast by Regions (2017-2022)
Table Global Urology Drugs Sales Forecast by Type (2017-2022)
Table Global Urology Drugs Sales Forecast by Application (2017-2022)